Ability biologics
Ville-marie
About Ability biologics
Ability biologics develops novel, tailored immune modifying biotherapeutics to address unmet medical requirements in cancer and autoimmune disease patients.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 1 – 10
- Total funding: $30.0M
- Funding stage: Seed
- Last round: Seed (Jun 2024)
- Website: ability.bio
- Phone: [email protected]
Industries & Categories
Biotechnology, Life Science
Social Profiles
Canonical: https://fsome.com/organization/ability-biologics-106720 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.